DK0610078T3 - Cytotoksisk og antiviral forbindelse. - Google Patents

Cytotoksisk og antiviral forbindelse.

Info

Publication number
DK0610078T3
DK0610078T3 DK94300780.7T DK94300780T DK0610078T3 DK 0610078 T3 DK0610078 T3 DK 0610078T3 DK 94300780 T DK94300780 T DK 94300780T DK 0610078 T3 DK0610078 T3 DK 0610078T3
Authority
DK
Denmark
Prior art keywords
cytotoxic
antiviral compound
compound
kalahide
sacoglossan
Prior art date
Application number
DK94300780.7T
Other languages
Danish (da)
English (en)
Inventor
Paul J Schauer
Dolores G Gravalos
Mark T Hamann
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of DK0610078T3 publication Critical patent/DK0610078T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK94300780.7T 1993-02-03 1994-02-02 Cytotoksisk og antiviral forbindelse. DK0610078T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302046A GB9302046D0 (en) 1993-02-03 1993-02-03 Antiumoral compound-v

Publications (1)

Publication Number Publication Date
DK0610078T3 true DK0610078T3 (da) 1997-10-20

Family

ID=10729727

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94300780.7T DK0610078T3 (da) 1993-02-03 1994-02-02 Cytotoksisk og antiviral forbindelse.

Country Status (11)

Country Link
EP (1) EP0610078B1 (de)
JP (1) JP3452628B2 (de)
AT (1) ATE151776T1 (de)
AU (1) AU677258B2 (de)
CA (1) CA2114859C (de)
DE (1) DE69402576T2 (de)
DK (1) DK0610078T3 (de)
ES (1) ES2102772T3 (de)
GB (1) GB9302046D0 (de)
GR (1) GR3024028T3 (de)
ZA (1) ZA94748B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
NZ525243A (en) 2000-10-31 2005-01-28 Pharma Mar S A lyophilised formulation comprising kahalalide F, a peptide isolated from a herbivorous marine species of mollusc, Elysia rufescens, to treat cancer
RU2292216C2 (ru) * 2000-10-31 2007-01-27 Фарма Мар, С.А. Кахалалид f
EP1435990A1 (de) * 2001-10-19 2004-07-14 Pharma Mar, S.A. Kahalalid-verbindungen zur verwendung in der krebstherapie
EP1572726B1 (de) * 2002-10-18 2010-12-08 Pharma Mar, S.A.U. 4-methylhexanoic kahalalide f verbindung
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
KR101149095B1 (ko) * 2002-10-18 2012-05-30 파르마 마르 에스.에이.유. 4-메틸헥사노 카할라리드 f 화합물
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
WO2009052379A2 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
EP2262522A1 (de) * 2008-03-07 2010-12-22 Pharma Mar, S.A. Verbesserte antitumorale behandlungen
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0358418B1 (de) * 1988-09-05 1992-12-16 Sankyo Company Limited Cyclisches Peptid, seine Herstellung und seine Verwendung zur Behandlung von cardiovasculären Störungen
US4986988A (en) * 1989-05-18 1991-01-22 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13

Also Published As

Publication number Publication date
ATE151776T1 (de) 1997-05-15
CA2114859A1 (en) 1994-08-04
EP0610078B1 (de) 1997-04-16
AU677258B2 (en) 1997-04-17
AU5491194A (en) 1994-08-11
GB9302046D0 (en) 1993-03-24
DE69402576D1 (de) 1997-05-22
GR3024028T3 (en) 1997-10-31
CA2114859C (en) 2008-04-15
DE69402576T2 (de) 1997-10-02
JPH0770185A (ja) 1995-03-14
JP3452628B2 (ja) 2003-09-29
ES2102772T3 (es) 1997-08-01
EP0610078A1 (de) 1994-08-10
ZA94748B (en) 1994-09-29

Similar Documents

Publication Publication Date Title
ATE269290T1 (de) Benzoylderivate
TW226375B (de)
NZ234327A (en) Quinazoline derivatives and pharmaceutical compositions
FI905983A0 (fi) Aminosyraderivat.
DE69426904D1 (de) Phosphonat-Nukleotid Ester-Derivate
HU9402342D0 (en) Phosphono-oxymethyl-ethers of taxane derivatives
CA2075173A1 (en) Compounds and methods for inhibition of hiv and related viruses
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
DK15589A (da) Kemiske forbindelser
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
ZA903983B (en) Diarylstyrylquinoline diacids
DK0509398T3 (da) Quinoxaliner, fremgangsmåder til deres fremstilling samt deres anvendelse
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
IL87421A0 (en) Pharmaceutical compositions containing 5-amino(or substituted amino)-1,2,3-triazoles
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
FI960658A0 (fi) Uudet bis-naftalimidit syövän hoitamiseksi
GR3022604T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
DK638787D0 (da) Anthracyclinderivater, deres fremstilling og anvendelse
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
DK656889A (da) Azabicykliske derivater
DK0381114T3 (da) Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf
ES2053808T3 (es) Nuevos compuestos azolicos.